Let us know who you are and what innovation & entrepreneurship programs, services or information you are interested in.Go
The Pitt Ventures First Gear program helps shape Pitt inventions originating from University research from early-stage discoveries into products and…Learn More
The Innovation Showcase is a first look at the latest Pitt-generated innovations in health care, materials, Internet of things, information…Learn More
Global Entrepreneurship Week started with an idea in 2008. What if there was a global…Learn More
Coulter Translational Research Partners II is administered by the Swanson School of Engineering Bioengineering Department, in partnership with the Pitt…Learn More
Join us for a Intro to Programming workshop facilitated by Tech Elevator Instructors Tom Medvitz and Tom Anderson. Participants will work…Learn More
LifeX Labs offers innovators and entrepreneurs the opportunity to consult with experienced and trusted service providers at no cost. These…Learn More
Most financing options require a solid business plan. Learn all you need to know about operational and production planning, conducting…Learn More
WIB-Pittsburgh: Hat-O-Ween at Howl at the Moon Hat-O-Ween is here! Pull out your crafting supplies and make a Halloween inspired…Learn More
Cumulative startups since inception
The Pitt Innovation Challenge (PInCh), in its fourth year, selected projects to treat dry eye with a contact lens coated with a sustained release new drug; a heart valve replacement made from a biodegradable material that recruits the patient's own cells; and a new test for the HIV virus that combines speed and accuracy.
Pitt innovators received five U.S. patents in September 2019, including for a surgical device to stop bleeding for battlefield and other traumatic wounds while maintaining blood flow to parts of the body distal to the injury.
Pitt spinout Renerva LLC received grants from the National Science Foundation and National Institutes of Health to expand its product development efforts. The company, based on technology from the lab of Bryan Brown, associate professor of bioengineering, is developing an injectable gel derived from porcine tissue that promotes and supports repair and regeneration of injured peripheral nerves.
Oncorus, which licensed technology developed in the lab of Pitt professor Joseph Glorioso, said it raised the Series B round with the goal of beginning trials early in 2020 for its oncolytic virus therapy targeting lung and other cancers.